Islet Sciences Inc Share Price

Stocks

Delayed OTC Markets 07:23:58 26/07/2017 pm IST			5-day change	1st Jan Change
0.0127 ^USD	+5.75%		+5.75%	-76.93%

04/15/04	Islet Sciences, Inc. Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH	GL
23/15/23	Islet Sciences, Inc. Presented at 50th International Liver Conference	GL
24/15/24	Islet Sciences, Inc. COO to Present at Metabolic Leaders Forum	GL
09/15/09	Islet Sciences, Inc. COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)	GL
05/15/05	Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD	GL

1 day

+5.75%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ISLET SCIENCES INC	+5.75%	+5.75%	-	-	0
LONZA GROUP AG	+0.76%	-0.99%	+3.26%	+17.50%	4.97TCr
REVOLUTION MEDICINES, INC.	+2.09%	-0.71%	+452.73%	+498.77%	4.5TCr
IQVIA HOLDINGS INC.	-1.09%	-0.41%	+35.40%	+15.17%	4.25TCr
BEONE MEDICINES AG	-0.26%	-4.71%	+17.19%	+71.67%	4.08TCr
CELLTRION, INC.	-0.48%	-0.84%	+16.25%	+49.80%	3.29TCr
ASCENDIS PHARMA A/S	-1.06%	+2.87%	-	-	1.71TCr
MEDPACE HOLDINGS, INC.	-1.81%	-5.02%	+22.65%	+113.24%	1.63TCr
EUROFINS SCIENTIFIC SE	+0.28%	-1.46%	+16.87%	+26.29%	1.44TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-2.05%	-5.14%	+72.89%	+34.69%	1.35TCr
Average	+0.05%	-2.44%	+79.65%	+103.39%	3.02TCr
Weighted average by Cap.	-0.31%	-2.27%	+97.47%	+122.33%